The dataset analysed within this paper is available in the corresponding author on reasonable request, and with appropriate additional ethical approvals, where required. Competing interests:

The Fc-fusion protein product shows superior results with an annualized bleeding rate (ABR) of 1 1.6 bleeding episodes with individualized prophylaxis and 3.6 bleeding episodes

J Am Coll Cardiol 1999;133:45A. 0.003). Seven yr mortality in the PCI group was also higher in comparison to CABG (23.6% CABG 44% PCI at

GFP-1we was the initial subunit to become overexpressed and incorporated in to the proteasome (Reits et al., 1997). 26S proteasome, poly-ubiquitinated model substrates will be